{"type": "FeatureCollection", "features": [{"id": "10.1038/s41467-022-28658-1", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:17Z", "type": "Journal Article", "created": "2022-02-25", "title": "Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases", "description": "Abstract<p>Soil-transmitted helminth infections represent a large burden with over a quarter of the world\uffe2\uff80\uff99s population at risk. Low cure rates are observed with standard of care (albendazole); therefore, a more effective combination therapy (albendazole and ivermectin) is being investigated but showed variable treatment efficacies without evidence of intrinsic parasite resistance. Here, we analyzed the microbiome ofTrichuris trichiuraand hookworm-infected patients and found an association of different enterotypes with treatment efficacy. 80\uffe2\uff80\uff89T. trichiura-infected patients with hookworm co-infections\uffc2\uffa0from Pak-Khan, Laos, received either albendazole (n\uffe2\uff80\uff89=\uffe2\uff80\uff8941) or albendazole and ivermectin combination therapy (n\uffe2\uff80\uff89=\uffe2\uff80\uff8939). Pre-/post-treatment stool samples were collected to monitor treatment efficacy and microbial communities were profiled using 16S rRNA gene sequencing, qPCR, and shotgun sequencing. We identified three bacterial enterotypes and show that pre-treatment enterotype is associated with efficacy of the combination treatment for bothT. trichiura(CRET1\uffe2\uff80\uff89=\uffe2\uff80\uff895.8%; CRET2\uffe2\uff80\uff89=\uffe2\uff80\uff8916.6%; CRET3\uffe2\uff80\uff89=\uffe2\uff80\uff8968.8%) and hookworm (CRET1\uffe2\uff80\uff89=\uffe2\uff80\uff8931.3%; CRET2\uffe2\uff80\uff89=\uffe2\uff80\uff8916.6%; CRET3\uffe2\uff80\uff89=\uffe2\uff80\uff8978.6%). This study shows that pre-treatment enterotype enables predicting treatment outcome of combination therapy forT. trichiuraand hookworm infections.</p><p>Trial registration: ClinicalTrials.gov, NCT03527732. Registered 17 May 2018,https://clinicaltrials.gov/ct2/show/NCT03527732.</p", "keywords": ["Anthelmintics", "Ivermectin", "Science", "Microbiota", "Q", "Helminthiasis", "Albendazole", "Article", "3. Good health", "Feces", "Soil", "RNA", " Ribosomal", " 16S", "Humans", "Trichuriasis", "Parasite Egg Count"]}, "links": [{"href": "https://edoc.unibas.ch/90817/1/20221201125904_638897089240d.pdf"}, {"href": "https://doi.org/10.1038/s41467-022-28658-1"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Nature%20Communications", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1038/s41467-022-28658-1", "name": "item", "description": "10.1038/s41467-022-28658-1", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1038/s41467-022-28658-1"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2022-02-25T00:00:00Z"}}, {"id": "10.1056/nejmoa2212825", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:28Z", "type": "Journal Article", "created": "2023-05-17", "title": "Emodepside for             Trichuris trichiura             and Hookworm Infection", "description": "Current treatments for soil-transmitted helminth infections in humans have low efficacy against Trichuris trichiura. Emodepside - a drug in veterinary use and under development for the treatment of onchocerciasis in humans - is a leading therapeutic candidate for soil-transmitted helminth infection.We conducted two phase 2a, dose-ranging, randomized, controlled trials to evaluate the efficacy and safety of emodepside against T. trichiura and hookworm infections. We randomly assigned, in equal numbers, adults 18 to 45 years of age in whom T. trichiura or hookworm eggs had been detected in stool samples to receive emodepside, at a single oral dose of 5, 10, 15, 20, 25, or 30 mg; albendazole, at a single oral dose of 400 mg; or placebo. The primary outcome was the percentage of participants who were cured of T. trichiura or hookworm infection (the cure rate) with emodepside 14 to 21 days after treatment, determined with the use of the Kato-Katz thick-smear technique. Safety was assessed 3, 24, and 48 hours after the receipt of treatment or placebo.A total of 266 persons were enrolled in the T. trichiura trial and 176 in the hookworm trial. The predicted cure rate against T. trichiura in the 5-mg emodepside group (85% [95% confidence interval {CI}, 69 to 93]; 25 of 30 participants) was higher than the predicted cure rate in the placebo group (10% [95% CI, 3 to 26]; 3 of 31 participants) and the observed cure rate in the albendazole group (17% [95% CI, 6 to 35]; 5 of 30 participants). A dose-dependent relationship was shown in participants with hookworm: the observed cure rate was 32% (95% CI, 13 to 57; 6 of 19 participants) in the 5-mg emodepside group and 95% (95% CI, 74 to 99.9; 18 of 19 participants) in the 30-mg emodepside group; the observed cure rates were 14% (95% CI, 3 to 36; 3 of 21 participants) in the placebo group and 70% (95% CI, 46 to 88; 14 of 20 participants) in the albendazole group. In the emodepside groups, headache, blurred vision, and dizziness were the most commonly reported adverse events 3 and 24 hours after treatment; the incidence of events generally increased in a dose-dependent fashion. Most adverse events were mild in severity and were self-limited; there were few moderate and no serious adverse events.Emodepside showed activity against T. trichiura and hookworm infections. (Funded by the European Research Council; ClinicalTrials.gov number, NCT05017194.).", "keywords": ["Adult", "Dose-Response Relationship", " Drug", "Antinematodal Agents", "Administration", " Oral", "Middle Aged", "Albendazole", "16. Peace & justice", "3. Good health", "03 medical and health sciences", "Feces", "Hookworm Infections", "Soil", "Young Adult", "0302 clinical medicine", "Trichuris", "Depsipeptides", "Animals", "Humans", "Trichuriasis"]}, "links": [{"href": "https://doi.org/10.1056/nejmoa2212825"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/New%20England%20Journal%20of%20Medicine", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1056/nejmoa2212825", "name": "item", "description": "10.1056/nejmoa2212825", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1056/nejmoa2212825"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-05-18T00:00:00Z"}}, {"id": "11343/246714", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:22:30Z", "type": "Journal Article", "created": "2019-01-14", "title": "Exclusive dependence of IL-10R\u03b1 signalling on intestinal microbiota homeostasis and control of whipworm infection", "description": "The whipworm Trichuris trichiura is a soil-transmitted helminth that dwells in the epithelium of the caecum and proximal colon of their hosts causing the human disease, trichuriasis. Trichuriasis is characterized by colitis attributed to the inflammatory response elicited by the parasite while tunnelling through intestinal epithelial cells (IECs). The IL-10 family of receptors, comprising combinations of subunits IL-10R\u03b1, IL-10R\u03b2, IL-22R\u03b1 and IL-28R\u03b1, modulates intestinal inflammatory responses. Here we carefully dissected the role of these subunits in the resistance of mice to infection with T. muris, a mouse model of the human whipworm T. trichiura. Our findings demonstrate that whilst IL-22R\u03b1 and IL-28R\u03b1 are dispensable in the host response to whipworms, IL-10 signalling through IL-10R\u03b1 and IL-10R\u03b2 is essential to control caecal pathology, worm expulsion and survival during T. muris infections. We show that deficiency of IL-10, IL-10R\u03b1 and IL-10R\u03b2 results in dysbiosis of the caecal microbiota characterised by expanded populations of opportunistic bacteria of the families Enterococcaceae and Enterobacteriaceae. Moreover, breakdown of the epithelial barrier after whipworm infection in IL-10, IL-10R\u03b1 and IL-10R\u03b2-deficient mice, allows the translocation of these opportunistic pathogens or their excretory products to the liver causing organ failure and lethal disease. Importantly, bone marrow chimera experiments indicate that signalling through IL-10R\u03b1 and IL-10R\u03b2 in haematopoietic cells, but not IECs, is crucial to control worm expulsion and immunopathology. These findings are supported by worm expulsion upon infection of conditional mutant mice for the IL-10R\u03b1 on IECs. Our findings emphasize the pivotal and complex role of systemic IL-10R\u03b1 signalling on immune cells in promoting microbiota homeostasis and maintaining the intestinal epithelial barrier, thus preventing immunopathology during whipworm infections.", "keywords": ["0301 basic medicine", "Lydia Becker Institute", "QH301-705.5", "610", "Interleukin-22", "Mice", "03 medical and health sciences", "Animals", "Homeostasis", "Receptors", " Interleukin-10", "Trichuriasis", "Biology (General)", "Interleukins", "RC581-607", "Gastrointestinal Microbiome", "Interleukin-10", "3. Good health", "Intestines", "Mice", " Inbred C57BL", "Disease Models", " Animal", "Trichuris", "Cytokines", "Immunologic diseases. Allergy", "ResearchInstitutes_Networks_Beacons/lydia_becker_institute_of_immunology_and_inflammation; name=Lydia Becker Institute", "Research Article", "Signal Transduction"]}, "links": [{"href": "https://doi.org/11343/246714"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/PLOS%20Pathogens", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "11343/246714", "name": "item", "description": "11343/246714", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/11343/246714"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2019-01-14T00:00:00Z"}}, {"id": "37195942", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:35Z", "type": "Journal Article", "created": "2023-05-17", "title": "Emodepside for             Trichuris trichiura             and Hookworm Infection", "description": "Current treatments for soil-transmitted helminth infections in humans have low efficacy against Trichuris trichiura. Emodepside - a drug in veterinary use and under development for the treatment of onchocerciasis in humans - is a leading therapeutic candidate for soil-transmitted helminth infection.We conducted two phase 2a, dose-ranging, randomized, controlled trials to evaluate the efficacy and safety of emodepside against T. trichiura and hookworm infections. We randomly assigned, in equal numbers, adults 18 to 45 years of age in whom T. trichiura or hookworm eggs had been detected in stool samples to receive emodepside, at a single oral dose of 5, 10, 15, 20, 25, or 30 mg; albendazole, at a single oral dose of 400 mg; or placebo. The primary outcome was the percentage of participants who were cured of T. trichiura or hookworm infection (the cure rate) with emodepside 14 to 21 days after treatment, determined with the use of the Kato-Katz thick-smear technique. Safety was assessed 3, 24, and 48 hours after the receipt of treatment or placebo.A total of 266 persons were enrolled in the T. trichiura trial and 176 in the hookworm trial. The predicted cure rate against T. trichiura in the 5-mg emodepside group (85% [95% confidence interval {CI}, 69 to 93]; 25 of 30 participants) was higher than the predicted cure rate in the placebo group (10% [95% CI, 3 to 26]; 3 of 31 participants) and the observed cure rate in the albendazole group (17% [95% CI, 6 to 35]; 5 of 30 participants). A dose-dependent relationship was shown in participants with hookworm: the observed cure rate was 32% (95% CI, 13 to 57; 6 of 19 participants) in the 5-mg emodepside group and 95% (95% CI, 74 to 99.9; 18 of 19 participants) in the 30-mg emodepside group; the observed cure rates were 14% (95% CI, 3 to 36; 3 of 21 participants) in the placebo group and 70% (95% CI, 46 to 88; 14 of 20 participants) in the albendazole group. In the emodepside groups, headache, blurred vision, and dizziness were the most commonly reported adverse events 3 and 24 hours after treatment; the incidence of events generally increased in a dose-dependent fashion. Most adverse events were mild in severity and were self-limited; there were few moderate and no serious adverse events.Emodepside showed activity against T. trichiura and hookworm infections. (Funded by the European Research Council; ClinicalTrials.gov number, NCT05017194.).", "keywords": ["Adult", "Dose-Response Relationship", " Drug", "Antinematodal Agents", "Administration", " Oral", "Middle Aged", "Albendazole", "16. Peace & justice", "3. Good health", "03 medical and health sciences", "Feces", "Hookworm Infections", "Soil", "Young Adult", "0302 clinical medicine", "Trichuris", "Depsipeptides", "Animals", "Humans", "Trichuriasis"]}, "links": [{"href": "https://doi.org/37195942"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/New%20England%20Journal%20of%20Medicine", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "37195942", "name": "item", "description": "37195942", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/37195942"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-05-18T00:00:00Z"}}, {"id": "PMC8881608", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:25:04Z", "type": "Journal Article", "created": "2022-02-25", "title": "Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases", "description": "Abstract                   <p>                     Soil-transmitted helminth infections represent a large burden with over a quarter of the world\uffe2\uff80\uff99s population at risk. Low cure rates are observed with standard of care (albendazole); therefore, a more effective combination therapy (albendazole and ivermectin) is being investigated but showed variable treatment efficacies without evidence of intrinsic parasite resistance. Here, we analyzed the microbiome of                     Trichuris trichiura                     and hookworm-infected patients and found an association of different enterotypes with treatment efficacy. 80\uffe2\uff80\uff89                     T. trichiura                     -infected patients with hookworm co-infections\uffc2\uffa0from Pak-Khan, Laos, received either albendazole (                     n                     \uffe2\uff80\uff89=\uffe2\uff80\uff8941) or albendazole and ivermectin combination therapy (                     n                     \uffe2\uff80\uff89=\uffe2\uff80\uff8939). Pre-/post-treatment stool samples were collected to monitor treatment efficacy and microbial communities were profiled using 16S rRNA gene sequencing, qPCR, and shotgun sequencing. We identified three bacterial enterotypes and show that pre-treatment enterotype is associated with efficacy of the combination treatment for both                     T. trichiura                     (CR                     ET1                     \uffe2\uff80\uff89=\uffe2\uff80\uff895.8%; CR                     ET2                     \uffe2\uff80\uff89=\uffe2\uff80\uff8916.6%; CR                     ET3                     \uffe2\uff80\uff89=\uffe2\uff80\uff8968.8%) and hookworm (CR                     ET1                     \uffe2\uff80\uff89=\uffe2\uff80\uff8931.3%; CR                     ET2                     \uffe2\uff80\uff89=\uffe2\uff80\uff8916.6%; CR                     ET3                     \uffe2\uff80\uff89=\uffe2\uff80\uff8978.6%). This study shows that pre-treatment enterotype enables predicting treatment outcome of combination therapy for                     T. trichiura                     and hookworm infections.                   </p>                   <p>                     Trial registration: ClinicalTrials.gov, NCT03527732. Registered 17 May 2018,                     https://clinicaltrials.gov/ct2/show/NCT03527732                     .                   </p", "keywords": ["Anthelmintics", "Ivermectin", "Science", "Microbiota", "Q", "Helminthiasis", "Albendazole", "Article", "3. Good health", "Feces", "Soil", "RNA", " Ribosomal", " 16S", "Humans", "Trichuriasis", "Parasite Egg Count"]}, "links": [{"href": "https://edoc.unibas.ch/90817/1/20221201125904_638897089240d.pdf"}, {"href": "https://doi.org/PMC8881608"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Nature%20Communications", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "PMC8881608", "name": "item", "description": "PMC8881608", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/PMC8881608"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2022-02-25T00:00:00Z"}}], "links": [{"rel": "self", "type": "application/geo+json", "title": "This document as GeoJSON", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Trichuriasis&f=json", "hreflang": "en-US"}, {"rel": "alternate", "type": "text/html", "title": "This document as HTML", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Trichuriasis&f=html", "hreflang": "en-US"}, {"rel": "collection", "type": "application/json", "title": "Collection URL", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main", "hreflang": "en-US"}, {"type": "application/geo+json", "rel": "first", "title": "items (first)", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Trichuriasis&", "hreflang": "en-US"}, {"rel": "last", "type": "application/geo+json", "title": "items (last)", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=Trichuriasis&offset=5", "hreflang": "en-US"}], "numberMatched": 5, "numberReturned": 5, "distributedFeatures": [], "timeStamp": "2026-11-22T18:09:21.982766Z"}